| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5723838cfc3775d34156e4604ba8d4d7 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 |
| filingDate |
2011-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a6f33792edba51217af955da6d2a306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5efb4f9d5542211d67caca52c15fccb |
| publicationDate |
2013-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201306832-A |
| titleOfInvention |
Composition and method for treating myelodysplastic syndrome |
| abstract |
The present invention generally relates to compositions and methods for treating myelodysplastic syndromes. In one embodiment, the invention relates to the use of Ezastast or a salt thereof in combination with lenalidomide to treat myelodysplasia in a patient treated with a DNA methyltransferase inhibitor with Ezstat or a salt thereof The method of syndrome. |
| priorityDate |
2011-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |